Beranda › Kanker Paru Non-Sel Kecil › Illinois › Champaign
Uji klinis Kanker Paru Non-Sel Kecil di Champaign, IL
11 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Champaign (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Carle Cancer Center, Urbana · 2 mi jauhnya
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Menerima pesertaFase 3
- Carle Cancer Center, Urbana · 2 mi jauhnya
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Menerima pesertaFase 3
- Local Institution - 0423, Urbana · 2 mi jauhnya
Pan-tumor MRD Study
Menerima pesertaStudi observasional
- Carle Health, Urbana · 2 mi jauhnya
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Menerima pesertaFase 2
- Carle Cancer Center, Urbana · 2 mi jauhnya
- The Carle Foundation Hospital, Urbana · 2 mi jauhnya
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Menerima pesertaFase 1/2
- Carle Cancer Institute, Urbana · 2 mi jauhnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Carle Cancer Center, Urbana · 2 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Carle Cancer Center, Urbana · 2 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Carle Cancer Center, Urbana · 2 mi jauhnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Carle Cancer Center, Urbana · 2 mi jauhnya
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Carle Cancer Center, Urbana · 2 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY120 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH56 studi
- Washington, DC55 studi
Studi lain di Champaign
- Kanker Payudara11 studi
- Kanker Paru9 studi
- Kanker Prostat8 studi
- Kanker Endometrium6 studi
- Kanker (semua jenis)6 studi
- Karsinoma Sel Skuamosa Kepala dan Leher6 studi
- Melanoma6 studi
- Kanker Kolorektal6 studi
- Kanker Laring5 studi
- Kanker Mulut5 studi
- Kanker Ginjal (Karsinoma Sel Renal)5 studi
- Kanker Pankreas5 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.